Copy For Citation
Kus T., Aktas G., Sevinc A., KALENDER M. E., YILMAZ M., KUL S., ...More
ONCOTARGETS AND THERAPY, vol.8, pp.3749-3756, 2015 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
8
-
Publication Date:
2015
-
Doi Number:
10.2147/ott.s94945
-
Journal Name:
ONCOTARGETS AND THERAPY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.3749-3756
-
Keywords:
lung adenocarcinoma, erlotinib, F-18-fluorodeoxyglucose positron emission tomography/computed tomography, maximum standardized uptake value, treatment response, prognosis, PLATINUM-BASED CHEMOTHERAPY, OPEN-LABEL, PHASE-III, 2ND-LINE TREATMENT, SMOKING HISTORY, SUPPORTIVE CARE, EGFR MUTATIONS, CANCER, GEFITINIB, MULTICENTER
-
Akdeniz University Affiliated:
Yes
Abstract
Purpose: To investigate whether the initial maximum standardized uptake value (SUVmax) on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) has a prognostic significance in metastatic lung adenocarcinoma.